Cooper Rice-Brading Foundation

The Cooper Rice-Brading Foundation (CRBF) is dedicated to the fight against sarcoma, a cancer of the connective tissue and bone, affecting all ages, but disproportionately affecting children, adolescents and young adults.

Cooper Rice-Brading was a robust, sport-loving teenager entering his HSC year, when a suspected cricket injury revealed the sinister diagnosis of osteosarcoma.
The early stages of Cooper’s treatment saw him posing endless questions to his medical team, to learn more about sarcoma. He discovered there had been little significant change to survival outcomes and treatment options for sarcoma patients in almost four decades. Cooper’s mission, conceived from his hospital bed, was to change the current trajectory of sarcoma, whilst courageously facing the reality his work was unlikely to assist him.
On March 28, 2017, Cooper launched the Foundation which would proudly bear his name - aspiring to make sarcoma history. Cooper tragically lost his life to sarcoma some four months later, on August 24, 2017. He was 18 years old.
Cooper’s memory and vision lives on in the legacy he left behind. CRBF has grown exponentially to be one of the two largest sarcoma NGO’s in Australia, generating funding for critical high level sarcoma research, creating awareness of this sinister cancer in the community, and supporting patients and families from diagnosis, throughout treatment and beyond.
In March this year the IL23 sarcoma sub study conducted through the Garvan Institute of Medical Research began recruiting its first patients. This clinical trial sees CRBF as a major funding partner, and provides untold hope for those who are living with a sarcoma diagnosis.
On July 1, 2021, CRBF will announce the funding for the Sarcoma Phosphoproteomic Study at the Children’s Cancer Institute of Australia, which will provide high level tumour analysis for paediatric and adolescent sarcoma patients.

Contact

14 Macleay St
Potts Point NSW 1335
Australia